Brief: Atara Biotherapeutics Says FDA Lifts Clinical Hold Enabling Resumption Of Clinical Trials
05/05/2025 22:08
May 5 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS INC - FDA LIFTS CLINICAL HOLD ENABLING RESUMPTION OF CLINICAL TRIALS ATARA BIOTHERAPEUTICS INC - FDA HAS GRANTED A TYPE A MEETING TO DISCUSS PATH FORWARD FOR BLA Source text: ID:nBw4h1DVMa Further company coverage: ATRA.O ((Reuters.Brief@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM